P/FCFE

40.7
Current
31%
More Expensive
vs 3-y average of 31.1

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
40.7
=
Market Cap
€5.4B
/
Free Cash Flow to Equity
€129.5m

Price to Free Cash Flow to Equity (P/FCFE) ratio compares a company`s market value to the free cash flow available to its shareholders. It`s similar to the P/OCF ratio but more precise, since it accounts for capital expenditures deducted from operating cash flow.

P/FCFE
40.7
=
Market Cap
€5.4B
/
Free Cash Flow to Equity
€129.5m

Valuation Scenarios

SOL SpA is trading above its 3-year average

If P/FCFE returns to its 3-Year Average (31.1), the stock would be worth €44.07 (23% downside from current price).

Statistics
Positive Scenarios
1/4
Maximum Downside
-52%
Maximum Upside
+134%
Average Upside
9%
Scenario P/FCFE Value Implied Price Upside/Downside
Current Multiple 40.7 €57.6
0%
3-Year Average 31.1 €44.07
-23%
5-Year Average 31.1 €44.07
-23%
Industry Average 95.1 €134.6
+134%
Country Average 19.4 €27.47
-52%

Forward P/FCFE
Today’s price vs future free cash flow to equity

Not enough data available to calculate forward P/FCFE

Peer Comparison

All Multiples
P/FCFE
P/E
All Countries
Close

Market Distribution

Higher than 80% of companies in Italy
Percentile
80th
Based on 563 companies
80th percentile
40.7
Low
0.9 — 11.9
Typical Range
11.9 — 28.4
High
28.4 —
Distribution Statistics
Italy
Min 0.9
30th Percentile 11.9
Median 19.4
70th Percentile 28.4
Max 10 354.4

SOL SpA
Glance View

In the bustling industrial landscape of Italy, SOL SpA has carved its niche as a pivotal player in the realm of industrial gas and healthcare services. Established in 1927, the company has a rich legacy of innovation and adaptation, supplying essential gases like oxygen, nitrogen, and argon to a variety of industries—ranging from metalwork and electronics to food and beverage. Over the years, SOL expanded its horizons beyond the traditional industrial sector, entering into the healthcare market with a focus on homecare services. This diversification not only amplified its market reach but also cushioned its revenues against the cyclicality typically associated with industrial sectors. SOL SpA's financial success hinges on its dual operating strategy: producing and distributing industrial gases while providing critical healthcare services. In the gases segment, the company boasts a network of advanced production facilities and a sophisticated logistics system, enabling the efficient distribution of these gases across Europe and beyond. Meanwhile, the healthcare segment, which includes home respiratory therapies and medical equipment supplies, ensures a steady stream of income by tapping into the ever-growing demand for at-home medical care. This balanced portfolio allows SOL SpA to maintain a robust revenue stream, harnessing the stability of the healthcare sector while continuing to innovate and serve the dynamic industrial landscape.

SOL Intrinsic Value
27.86 EUR
Overvaluation 52%
Intrinsic Value
Price €57.6
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett